These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29297663)

  • 1. [Aptamers in the Treatment of Bacterial Infections: Problems and Prospects].
    Zeninskaya NA; Kolesnikov AV; Ryabko AK; Shemyakin IG; Dyatlov IA; Kozyr AV
    Vestn Ross Akad Med Nauk; 2016; 71(5):350-8. PubMed ID: 29297663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.
    Ouellet E; Foley JH; Conway EM; Haynes C
    Biotechnol Bioeng; 2015 Aug; 112(8):1506-22. PubMed ID: 25727321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers and SELEX in Chemistry & Biology.
    Famulok M; Mayer G
    Chem Biol; 2014 Sep; 21(9):1055-8. PubMed ID: 25237853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry of aptamers.
    Veedu RN
    Curr Top Med Chem; 2015; 15(12):1065. PubMed ID: 25866280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers: current challenges and future prospects.
    Rozenblum GT; Lopez VG; Vitullo AD; Radrizzani M
    Expert Opin Drug Discov; 2016; 11(2):127-35. PubMed ID: 26630462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Study of Aptamer-Protein Target Identification Using the Chromatographic Approach.
    Drabik A; Ner-Kluza J; Mielczarek P; Civit L; Mayer G; Silberring J
    J Proteome Res; 2018 Jun; 17(6):2174-2181. PubMed ID: 29703078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs.
    Urak KT; Shore S; Rockey WM; Chen SJ; McCaffrey AP; Giangrande PH
    Methods; 2016 Jul; 103():167-74. PubMed ID: 26972786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combinatorial systematic evolution of ligands by exponential enrichment method for selection of aptamer against protein targets.
    Mondal B; Ramlal S; Lavu PS; Murali HS; Batra HV
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9791-803. PubMed ID: 26293334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Highlight of Recent Advances in Aptamer Technology and Its Application.
    Sun H; Zu Y
    Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of aptamers for targeted therapeutics.
    Ray P; Viles KD; Soule EE; Woodruff RS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements in Aptamer Discovery Technologies.
    Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
    Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status and Prospects of Aptamers as Drug Components.
    Mattice CM; DeRosa MC
    BioDrugs; 2015 Jun; 29(3):151-65. PubMed ID: 25985746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.